BioNTech To Supply 100M Coronavirus Vaccine Doses To Chinese Partner Fosun Pharma
Financial Times: BioNTech set to become first foreign jab to enter China market “BioNTech will supply 100m doses of its coronavirus vaccine to Chinese partner Fosun Pharma for use in mainland China next year in the country’s first publicly announced order of a foreign jab against the disease…” (Shepherd, 12/16).…